Search research articles
Contact Us
Filters
Showing results (741-750 of 1,211) with videos related to
Page
of 122
Sort By:
Circulation
|
September 15, 2004
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
David Aguilar, Scott D Solomon, Lars Køber, et al.
European Journal of Heart Failure
|
April 17, 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE
Pooja Dewan, João Pedro Ferreira, Jawad H Butt, et al.
JACC. Heart Failure
|
January 13, 2026
Lactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction: Insights From GALACTIC-HF
Ryohei Ono, Misato Chimura, Kieran F Docherty, et al.
Journal of the American College of Cardiology
|
January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials
Pablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
European Heart Journal
|
July 2, 2014
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
Mauro Gori, Michele Senni, Deepak K Gupta, et al.
European Journal of Heart Failure
|
February 14, 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
Athar A Badar, Ana C Perez-Moreno, Nathaniel M Hawkins, et al.
Circulation
|
February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
JACC. Heart Failure
|
May 8, 2025
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study
Vanessa Blumer, James L Januzzi, Yuxi Liu, et al.
European Heart Journal
|
May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S Desai, John J V McMurray, Milton Packer, et al.
ESC Heart Failure
|
April 15, 2023
Optimizing outcomes in heart failure: 2022 and beyond
Ewa A Jankowska, Tomas Andersson, Claudia Kaiser-Albers, et al.
Page
of 122
Search research articles
Search
Showing results (741-750 of 1,211) with videos related to
Sort By:
Page
of 122
Circulation
|
September 15, 2004
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
David Aguilar, Scott D Solomon, Lars Køber, et al.
European Journal of Heart Failure
|
April 17, 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE
Pooja Dewan, João Pedro Ferreira, Jawad H Butt, et al.
JACC. Heart Failure
|
January 13, 2026
Lactate Dehydrogenase and Outcomes in Patients With HF and Reduced Ejection Fraction: Insights From GALACTIC-HF
Ryohei Ono, Misato Chimura, Kieran F Docherty, et al.
Journal of the American College of Cardiology
|
January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials
Pablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
European Heart Journal
|
July 2, 2014
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
Mauro Gori, Michele Senni, Deepak K Gupta, et al.
European Journal of Heart Failure
|
February 14, 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
Athar A Badar, Ana C Perez-Moreno, Nathaniel M Hawkins, et al.
Circulation
|
February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
JACC. Heart Failure
|
May 8, 2025
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study
Vanessa Blumer, James L Januzzi, Yuxi Liu, et al.
European Heart Journal
|
May 30, 2015
Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S Desai, John J V McMurray, Milton Packer, et al.
ESC Heart Failure
|
April 15, 2023
Optimizing outcomes in heart failure: 2022 and beyond
Ewa A Jankowska, Tomas Andersson, Claudia Kaiser-Albers, et al.
Page
of 122